The Global Mycetoma Working Group (GMWG) was formed in January 2018 in response to the declaration of mycetoma as a neglected tropical disease (NTD) by the World Health Assembly. The aim of the working group is to connect experts and public health practitioners around the world to accelerate mycetoma prevention activities and reduce the impact of mycetoma on patients, healthcare providers and society in the endemic regions. The working group has made tangible contributions to mycetoma programming, awareness and coordination among scientists, clinicians and public health professionals. The group's connectivity has enabled rapid response and review of NTD documents in development, has created a network of public health professionals to provide regional mycetoma expertise and has enabled mycetoma to be represented within broader NTD organizations. The GMWG will continue to serve as a hub for networking and building collaborations for the advancement of mycetoma clinical management and treatment, research and public health programming.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423010 | PMC |
| http://dx.doi.org/10.1093/trstmh/traa163 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Seroprevalence Assessment of Anti-Varicella Antibodies among Adults in the Province of Florence (Italy).
Vaccines (Basel)
September 2024
Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Article Synopsis
- Around 90% of varicella (chickenpox) infections are mild, but adults can experience more severe cases, prompting a study in Florence, Italy, to assess immunity levels post-vaccination.
- A survey of 430 adults (ages 18-94) showed that 89.5% tested positive for varicella antibodies, with no significant differences based on sex or nationality.
- The findings indicated that while vaccination efforts have improved immunity, there is still a notable susceptibility (11.6%) among women aged 18-49, emphasizing the need for ongoing vaccination campaigns and awareness.
Outcome of primary hemophagocytic lymphohistiocytosis: a report on 143 patients from the Italian Registry.
Haematologica
August 2024
Antonino Trizzino, Simona Gobbi, Fraia Melchionda, Marco Zecca, Elena Mastrodicasa, Massimo Provenzi, Monica Cellini, Daniela Onofrillo, Marco Rabusin, Bernd Raffeiner, Rosamaria Mura, Vito Miraglia, Alessandra Tozzo.
Primary hemophagocytic lymphohistiocytosis (pHLH) is a severe, life-threatening hyperinflammatory syndrome caused by defects in genes of the granule-dependent cytotoxic pathway. Here we investigated the clinical presentation and outcome in a large cohort of 143 patients with pHLH diagnosed in the last 15 years and enrolled in the Italian registry. The median age at diagnosis was 12 months (interquartile range, 2-81), and 92 patients (64%) fulfilled the HLH-2004 criteria.
View Article and Find Full Text PDFArticle Synopsis
- Major serotypes of Shiga toxin-producing E. coli (STEC) usually have a specific genetic region called the locus of enterocyte effacement (LEE) which helps them cause infections by forming lesions on intestinal cells.* -
- There is limited information on STEC that lack this LEE, even though they can still be very harmful.* -
- This study reports the complete genomes of eight LEE-negative STEC isolates found in patients with hemolytic-uremic syndrome, contributing valuable data to the understanding of these bacteria.*
A European code of good practice for hyperbaric oxygen therapy - Review 2022.
Diving Hyperb Med
December 2023
Prepared by the Working Group «SAFETY» of the COST Action B14 «HYPERBARIC OXYGEN THERAPY» May 2004 - Update 2022.
Invasive Candidiasis in Adult Patients with COVID-19: Results of a Multicenter Study in St. Petersburg, Russia.
J Fungi (Basel)
September 2023
Kashkin Research Institute of Medical Mycology; North-Western State Medical University Named after I.I. Mechnikov, 191015 Saint-Petersburg, Russia.
We studied the risk factors, etiology, clinical manifestations, and treatment outcomes of COVID-19-associated invasive candidiasis (COVID-IC) in adult patients admitted to six medical facilities in St. Petersburg. (November 2020-December 2022).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!